Lantern Pharma (LTRN)'s 30-day implied volatility (IV30) was 127.1% at the close on November 10, 2026, against a 52-week range of 68.7% to 197.0%. Its 20-day historical volatility was 140.8%.
Key numbers
30-day implied volatility (IV30): 127.1%
IV30 52-week range: 68.7% to 197.0% (median 95.1%)